Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach
- PMID: 22203046
- DOI: 10.1007/s00167-011-1837-x
Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach
Abstract
Purpose: To compare the safety and efficacy of two different approaches of platelet-rich plasma (PRP) production methods as intra-articular injection treatment for knee cartilage degenerative lesions and osteoarthritis (OA).
Methods: The study involved 144 symptomatic patients affected by cartilage degenerative lesions and OA. Seventy-two patients were treated with 3 injections of platelet concentrate prepared with a single-spinning procedure (PRGF), the other 72 with 3 injections of PRP obtained with a double-spinning approach. The patients were evaluated prospectively at the enrollment and at 2, 6, and 12 months' follow-up with IKDC, EQ-VAS and Tegner scores; adverse events and patient satisfaction were also recorded.
Results: Both treatment groups presented a statistically significant improvement in all the scores evaluated at all the follow-up times. Better results were achieved in both groups in younger patients with a lower degree of cartilage degeneration. The comparative analysis showed similar improvements with the two procedures: in particular, IKDC subjective evaluation increased from 45.0 ± 10.1 to 59.0 ± 16.2, 61.3 ± 16.3, and 61.6 ± 16.2 at 2, 6, and 12 months in the PRGF group, and from 42.1 ± 13.5 to 60.8 ± 16.6, 62.5 ± 19.9, and 59.9 ± 20.0 at 2, 6, and 12 months in the PRP group, respectively. Concerning adverse events, more swelling (P = 0.03) and pain reaction (P = 0.0005), were found after PRP injections.
Conclusions: Although PRP injections produced more pain and swelling reaction with respect to that produced by PRGF, similar results were found at the follow-up times, with a significant clinical improvement with respect to the basal level. Better results were achieved in younger patients with a low degree of cartilage degeneration.
Level of evidence: II.
Comment in
-
The type of platelet-rich plasma may influence the safety of the approach.Knee Surg Sports Traumatol Arthrosc. 2014 Jul;22(7):1708-9. doi: 10.1007/s00167-012-2043-1. Epub 2012 May 9. Knee Surg Sports Traumatol Arthrosc. 2014. PMID: 22569632 No abstract available.
Similar articles
-
Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis.Arthroscopy. 2011 Nov;27(11):1490-501. doi: 10.1016/j.arthro.2011.05.011. Epub 2011 Aug 10. Arthroscopy. 2011. PMID: 21831567 Clinical Trial.
-
Platelet-Rich Plasma Intra-articular Knee Injections Show No Superiority Versus Viscosupplementation: A Randomized Controlled Trial.Am J Sports Med. 2015 Jul;43(7):1575-82. doi: 10.1177/0363546515582027. Epub 2015 May 7. Am J Sports Med. 2015. PMID: 25952818 Clinical Trial.
-
Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial.BMC Musculoskelet Disord. 2012 Nov 23;13:229. doi: 10.1186/1471-2474-13-229. BMC Musculoskelet Disord. 2012. PMID: 23176112 Free PMC article. Clinical Trial.
-
Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Am J Sports Med. 2021 Jan;49(1):249-260. doi: 10.1177/0363546520909397. Epub 2020 Apr 17. Am J Sports Med. 2021. PMID: 32302218
-
Intra-articular injection of platelet-rich plasma in patients with hemophilia and painful knee joint cartilage degeneration.Expert Rev Hematol. 2023 Jun;16(6):407-416. doi: 10.1080/17474086.2023.2166922. Epub 2023 Jan 12. Expert Rev Hematol. 2023. PMID: 36609192 Review.
Cited by
-
Autologous Protein Solution processing alters lymphoid and myeloid cell populations and modulates gene expression dependent on cell type.Arthritis Res Ther. 2022 Sep 12;24(1):221. doi: 10.1186/s13075-022-02875-x. Arthritis Res Ther. 2022. PMID: 36096945 Free PMC article.
-
Role of platelet rich plasma in management of early knee osteoarthritis pain: A retrospective observational study.Interv Pain Med. 2023 Nov 28;2(4):100297. doi: 10.1016/j.inpm.2023.100297. eCollection 2023 Dec. Interv Pain Med. 2023. PMID: 39239225 Free PMC article.
-
Efficacy and Safety of Hyaluronic Acid and Platelet-Rich Plasma Combination Therapy Versus Platelet-Rich Plasma Alone in Treating Knee Osteoarthritis: A Systematic Review.Cureus. 2023 Oct 18;15(10):e47256. doi: 10.7759/cureus.47256. eCollection 2023 Oct. Cureus. 2023. PMID: 38022237 Free PMC article. Review.
-
Application of Platelet-Rich Plasma to Disorders of the Knee Joint.Cartilage. 2013 Oct;4(4):295-312. doi: 10.1177/1947603513487553. Cartilage. 2013. PMID: 26069674 Free PMC article.
-
Comparison of Efficiency Between Corticosteroid and Platelet Rich Plasma Injection Therapies in Patients With Knee Osteoarthritis.Arch Rheumatol. 2017 Nov 2;33(3):273-281. doi: 10.5606/ArchRheumatol.2018.6608. eCollection 2018 Sep. Arch Rheumatol. 2017. PMID: 30632533 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials